The Slow Revolution | GenomeWeb

The Slow Revolution

Though the cost of whole-genome sequencing is falling dramatically, the University of Alberta's Timothy Caulfield writes in the Globe and Mail that having people's full genome sequences might not have as great an effect on their health as has been indicated. "The relationship between our genome and disease is far more complicated than originally anticipated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.